**Core Concept**
Recurrent Demyelinating Polyneuropathy (RD) is a rare autoimmune disorder characterized by recurrent episodes of peripheral neuropathy, typically involving the motor nerves. The condition is associated with the presence of antibodies against the ganglioside GM1, which is a component of the myelin sheath.

**Why the Correct Answer is Right**
The diagnosis of RD is primarily based on clinical presentation, electrophysiological studies, and the presence of anti-GM1 antibodies. The condition typically presents with acute or subacute onset of weakness, often in a length-dependent pattern, and may be accompanied by autonomic dysfunction. The presence of anti-GM1 antibodies in the serum is a useful diagnostic marker, although not all patients with RD may test positive. The antibodies are thought to contribute to the demyelination of peripheral nerves by activating complement and promoting the release of pro-inflammatory cytokines.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a diagnostic criterion for RD. While nerve conduction studies may show evidence of demyelination, they are not specific for RD.
**Option B:** This option is not a diagnostic test for RD. While electromyography (EMG) may show evidence of denervation, it is not specific for RD.
**Option C:** This option is not a diagnostic marker for RD. While the presence of anti-GM1 antibodies is a useful diagnostic marker, not all patients with RD may test positive.

**Clinical Pearl / High-Yield Fact**
RD is a rare but potentially treatable cause of recurrent peripheral neuropathy, and prompt diagnosis is essential to avoid unnecessary delay in treatment.

**Correct Answer:** A.